Skip to main content
Pharma Equity Group A/S logo

Pharma Equity Group A/S — Investor Relations & Filings

Ticker · BLVIS ISIN · DK0061155009 LEI · 2138008SUI4D917FKN20 CO Financial and insurance activities
Open in API
Filings indexed 1,627 across all filing types
Latest filing 2017-08-25 Interim / Quarterly Rep…
Country DK Denmark
Listing CO BLVIS

About Pharma Equity Group A/S

https://bcbsfepvision.com/

Pharma Equity Group A/S is an investment company specializing in early-stage biotechnology, life science, and MedTech companies. The group's mission is to support its portfolio companies in developing novel therapies and effective medicines for unmet medical needs. A primary investment is its subsidiary, Reponex Pharmaceuticals, a clinical-stage biopharmaceutical company focused on developing treatments for serious, acute, and chronic inflammatory diseases. The company is actively expanding its portfolio through strategic acquisitions to support its growth.

Recent filings

Filing Released Lang Actions
Interim / Quarterly Report 2017
Interim / Quarterly Report Classification · 100% confidence The document provides financial results for the period 1 January to 30 June 2017, including net profit and equity figures. It also contains a management discussion regarding business activities, strategic focus, and future outlook. Since it covers a period shorter than a full fiscal year and contains substantive financial data and analysis, it qualifies as an Interim/Quarterly Report. H1 2017
2017-08-25 Danish
Interim / Quarterly Report 2017
Interim / Quarterly Report Classification · 100% confidence The document is titled 'Delårsrapport' (Interim Report) for the period 1 January – 30 June 2017. It contains comprehensive financial statements, including a balance sheet, income statement, cash flow statement, and notes, as well as management commentary. It is not a mere announcement or certification, but the full interim financial report itself, fitting the definition of an Interim/Quarterly Report (IR). H1 2017
2017-08-25 English
Delårsrapportering 1. halvår 2017
Interim / Quarterly Report Classification · 100% confidence The document is titled 'Delårsrapportering 1. halvår 2017' (Interim Report for the first half of 2017). It contains specific financial data, including the net result after tax and equity figures for the period, as well as a management discussion on business activities and future outlook. It is not merely an announcement of a report, but the report itself, fitting the definition of an Interim/Quarterly Report (IR). H1 2017
2017-08-25 English
Director's Dealing 2017
Director's Dealing Classification · 95% confidence The document is very short (485 characters) and appears to be a notification regarding a change in share ownership following a share purchase ('Efter aktiekøb disponerer jeg over 9.500.000 aktier... hvilket svarer til 8,74% af den udstedte aktiekapital'). This directly relates to insider transactions or significant changes in major shareholdings. Since it is a notification about an executive/insider transaction (Johannes Møller Westh, likely a director or major shareholder, disclosing his new holding), the most appropriate category is Director's Dealing (DIRS) or Major Shareholding Notification (MRQ). Given the context of an individual executive/director disclosing their personal transaction, DIRS is slightly more specific than MRQ, which often covers institutional thresholds. However, the text explicitly states the resulting percentage (8.74%), which strongly aligns with the definition of Major Shareholding Notification (MRQ). I will classify it as MRQ as it focuses on the resulting percentage holding crossing a threshold, which is a common trigger for such filings.
2017-07-25 Danish
Major Shareholding Notification 2017
Major Shareholding Notification Classification · 98% confidence The document is very short (484 characters) and explicitly states it is a 'STORAKTIONÆRMEDDELELSE' (Major Shareholder Announcement) received by the company, detailing that an individual now controls 8.74% of the issued share capital after an acquisition. This directly corresponds to the definition of a notification of changes in significant share ownership levels crossing thresholds, which maps to the Major Shareholding Notification code (MRQ). Although it is a notification, the content itself is the core information (the change in holding), not just an announcement that a report is attached (which would suggest RPA/RNS).
2017-07-25 English
Major Shareholding Notification 2017
Major Shareholding Notification Classification · 98% confidence The document is very short (820 characters) and appears to be a notification received by Blue Vision A/S regarding a change in major shareholding. The text explicitly mentions 'Storaktionærmeddelelse' (Major Shareholder Notification) and details a reduction in ownership percentage (3.24%) by Marble Road Group ApS, citing Danish securities law (§ 29). This directly corresponds to the definition of Major Shareholding Notification (MRQ). Although it is a notification, the content is specific enough to classify it as MRQ rather than the general fallback RNS, as it details the change itself, not just the announcement of a report.
2017-07-25 Danish

Browse filings by year

20 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.